Compare ARK Genomic Revolution ETF (ARKG) vs Capital One Financial Corp. (COF) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Capital One Financial Corp. — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Capital One Financial Corp. trades at $202.4 (market cap $124.14B). The key difference: Capital One Financial Corp. pays a 1.59% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Capital One Financial Corp. nearer its low. Which is the better fit depends on your goals.
| ARKG | COF | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $257.94 |
52-Week Low | $23.09 | $176.10 |
Market Cap | — | $124.14B |
Dividend Yield | — | 1.59% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Capital One (COF) trades at $201.52, up 0.71% with a bearish technical signal but strong analyst support. The company reported mixed Q1 2026 earnings with a slight miss, while revenue surged to $53.43B in 2025. Key risks include subprime auto loan delinquencies and consumer credit stress, though the Discover integration offers long-term scale benefits. Technical indicators show neutral RSI readings with support at $195 and resistance at $203.
Wall Street maintains a bullish outlook with 62.5% buy ratings and a $256.25 consensus price target, representing 27% upside potential. However, declining profit margins and rising default risks in consumer lending create headwinds. The stock presents a compelling entry point for investors betting on operational improvements from recent acquisitions, though credit quality trends warrant close monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Capital One Financial Corp.
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.
Read more on COF →
